Boehringer Ingelheim Pharmaceuticals Building 10
Strategic scientific interaction
RecognitionIIDA Wisconsin Design Award, First Place
When the pharmaceutical company Boehringer Ingelheim embarked on a major expansion of its North American facilities, it was not simply to house more scientists. It was to expand science itself — pioneering important research in immunology and inflammation, and combating cardiovascular disease.
The striking campus features buildings set atop two steep hills with a valley and wetland areas running between. Building 10 curves gracefully with the natural contours of the land, offering views of the rolling Connecticut Hills while minimizing its own ecological impact. A welcoming entrance provides a gathering place for the research division, offering a café and conference space, in addition to consolidated and centralized administrative functions. Perhaps most importantly, a three-story, light-filled atrium connects related buildings and provides a central interaction hub for the scientific community.
Buildings are constructed for a purpose and the purpose of this building is a noble one -
to discover new treatments for human disease. But buildings should also inspire those within its walls,
and Building 10, despite its very modest name, achieves this.
Dr. Terence KellyVice PresidentMedicinal Chemistry